The store will not work correctly when cookies are disabled.
3,5-dichloro-N-[3-chloro-4-(2-hydroxyphenoxy)phenyl]-2-hydroxy-benzamide
ID: ALA4793138
PubChem CID: 162671597
Max Phase: Preclinical
Molecular Formula: C19H12Cl3NO4
Molecular Weight: 424.67
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccc(Oc2ccccc2O)c(Cl)c1)c1cc(Cl)cc(Cl)c1O
Standard InChI: InChI=1S/C19H12Cl3NO4/c20-10-7-12(18(25)14(22)8-10)19(26)23-11-5-6-16(13(21)9-11)27-17-4-2-1-3-15(17)24/h1-9,24-25H,(H,23,26)
Standard InChI Key: GFRCXQCDNRQTHG-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
14.0416 -19.8937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0424 -20.7169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7551 -21.1281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4633 -20.7131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4586 -19.8869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7495 -19.4835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1767 -21.1231 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8870 -20.7076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5976 -21.1220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3073 -20.7072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3046 -19.8850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5862 -19.4794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8794 -19.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5980 -21.9433 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
19.0143 -19.4728 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.7283 -19.8776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4380 -19.4654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7325 -20.6990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1462 -19.8724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8554 -19.4608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8516 -18.6387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1327 -18.2298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4305 -18.6479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7150 -18.2416 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1255 -17.4085 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
22.5692 -19.8661 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14.7578 -21.9453 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
9 14 1 0
11 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
23 24 1 0
22 25 1 0
20 26 1 0
3 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 424.67 | Molecular Weight (Monoisotopic): 422.9832 | AlogP: 6.10 | #Rotatable Bonds: 4 |
Polar Surface Area: 78.79 | Molecular Species: ACID | HBA: 4 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 5.95 | CX Basic pKa: ┄ | CX LogP: 5.77 | CX LogD: 4.37 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.47 | Np Likeness Score: -0.90 |
References
1. Fujii S,Kikuchi E,Watanabe Y,Suzuyama H,Ishigami-Yuasa M,Mori T,Isobe K,Uchida S,Kagechika H. (2020) Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling., 30 (17): [PMID:32738993] [10.1016/j.bmcl.2020.127408] |